Efficacy of Tenofovir-Based Combination Therapy versus Tenofovir Monotherapy in Chronic Hepatitis B Patients Presenting with Suboptimal Responses to Pretreatment: A Meta-Analysis

<div>Forest map of summary estimates for comparison of ALT normalization between TDF-based combination therapy and monotherapy groups. (a) 48-week ALT normalization; (b) 96-week ALT normalization.</div>

Gastroenterology Research and Practice

fig4

Figure 4

Figure 4: Efficacy of Tenofovir-Based Combination Therapy versus Tenofovir Monotherapy in Chronic Hepatitis B Patients Presenting with Suboptimal Responses to Pretreatment: A Meta-Analysis 

Figure 4 | Efficacy of Tenofovir-Based Combination Therapy versus Tenofovir Monotherapy in Chronic Hepatitis B Patients Presenting with Suboptimal Responses to Pretreatment: A Meta-Analysis 